4428
D. Maes et al. / Tetrahedron 62 (2006) 4426–4429
After stirring at room temperature for 24 h, the acetone was
evaporated in vacuo and the residue was chromatographed
over silica gel using 40% hexane, 50% diethyl ether and 10%
tetrahydrofuran as mobile phase. This procedure yielded 62%
(172 mg) of 8-hydroxy-6-methoxy-7-(30-methyl-20-butenyl-
oxy)coumarin (capensin) 8 (RfZ0.23) and 12% (21 mg)
7-hydroxy-6-methoxy-8-(30-methyl-20-butenyloxy)coumarin
9 (RfZ0.14), both appearing as a yellow powder.
7.62 (1H, d, 4-CH). 13C NMR (75 MHz, CDCl3): d 18.7 en
24.6 (2!CH3); 56.1 (OCH3); 59.3 (30-Cq); 61.5 (20-CH);
72.1 (10-CH2); 99.7 (5-CH); 114.6 (Cq); 115.2 (3-CH);
138.0 (2!Cq); 138.3 (Cq); 143.8 (4-CH); 149.8 (6-Cq);
160.6 (C]O). MS (70 eV, EI, m/z (%)): 292 (MC, 16); 208
(100); 193 (15); 139 (20); 85 (75); 83 (17); 71 (52); 69 (64);
55 (32); 49 (16); 43 (73).
3.2.3. Purpurasol 1.
8-Hydroxy-6-methoxy-7-(30-methyl-20-butenyloxy)-
coumarin (capensin) 8
Procedure 1
Mp (8C): 135 (lit. 135–1361). IR (KBr, cmK1): 3392 (broad,
OH); 1692 (C]O). H NMR (300 MHz, CDCl3): d 1.68
7-(2,3-Epoxy-3-methylbutoxy)-8-hydroxy-6-methoxycou-
marin 10 (29 mg, 0.1 mmol) was dissolved in 1 ml of
EtOAc. 0.05 mmol (7 mg) of potassium carbonate was
added and the reaction was stirred at room temperature for
24 h. Water (10 ml) and ethyl acetate (5 ml) were added,
and the aqueous phase was further extracted with 2!10 ml
of ethyl acetate. The combined organic layers were dried
(MgSO4) and, after filtration and evaporation of the solvent,
23 mg (79%) of purpurasol was obtained as a white
crystalline solid, which was recrystallized from ethanol.
1
(3H, s, 40-CH3); 1.75 (3H, s, 50-CH3); 3.90 (3H, s, OCH3);
4.69 (1H, d, JZ7.4 Hz, 10-CH2); 5.52 (1H, t, JZ7.4 Hz, 20-
CH); 6.16 (1H, br s, OH); 6.34 (1H, d, JZ9.6 Hz, 3-CH);
6.50 (1H, s, 5-CH); 7.62 (1H, d, JZ9.6 Hz, 4-CH). 13C
NMR (68 MHz, CDCl3): d 18.0 en 25.9 (2!CH3); 56.2
(OCH3); 70.0 (10-CH2); 100.0 (5-CH); 114.4 (Cq); 115.2 (3-
CH); 119.5 (20-CH); 137.8 (Cq); 138.0 (2!Cq); 140.5 (30-
Cq); 143.7 (4-CH); 149.8 (6-Cq); 160.4 (C]O). MS (70 eV,
ES, m/z (%)): 275 (MK1). Anal. Calcd for C15H16O5: C,
65.21%; H, 5.84%. Found: C, 65.01%; H, 5.68%.
Procedure 2
7-Hydroxy-6-methoxy-8-(30-methyl-20-butenyloxy)-
coumarin 9
8-Hydroxy-6-methoxy-7-(30-methyl-20-butenyloxy)-
coumarin (capensin) 8 (28 mg, 0.1 mmol) was dissolved in
1 ml of ethyl acetate. The reaction mixture was cooled to
0 8C and 20 mg (0.12 mmol) of 3-chloroperoxybenzoic acid
was added. The reaction was stirred at room temperature for
48 h. The solvent was evaporated and the resulting mixture
was dissolved in dichloromethane (10 ml) and washed with
10 ml of saturated aqueous sodium bicarbonate and 10 ml of
water, respectively. The organic phase was dried (MgSO4)
and, after filtration and evaporation of the solvent, 20 mg
(69%) of purpurasol was obtained as a white solid.
Mp (8C): 126.5. IR (KBr, cmK1): 3401 (broad, OH); 17002
1
(C]O). H NMR (300 MHz, CDCl3): d 1.70 (3H, s, 4 -
CH3); 1.75 (3H, s, 50-CH3); 3.93 (3H, s, OCH3); 4.80 (1H, d,
JZ7.4 Hz, 10-CH2); 5.55 (1H, t, JZ7.4 Hz, 20-CH); 6.27
(1H, d, JZ9.6 Hz, 3-CH); 6.66 (1H, s, 5-CH); 7.61 (1H, d,
JZ9.6 Hz, 4-CH). 13C NMR (75 MHz, CDCl3): d 18.1 en
25.9 (2!CH3); 56.4 (OCH3); 70.3 (10-CH2); 103.5 (5-CH);
111.1 (Cq); 113.3 (3-CH); 119.4 (20-CH); 133.1 (Cq); 140.6
(Cq); 143.0 (Cq); 143.2 (Cq); 143.9 (4-CH); 144.6 (6-Cq);
160.7 (C]O). MS (70 eV, ES, m/z (%)): 275 (MK1). Anal.
Calcd for C15H16O5: C, 65.21%; H, 5.84%. Found: C,
65.39%; H, 5.98%.
Mp (8C): 148 (lit. 148–1492). IR (KBr, cmK1): 3400 (broad,
OH); 1702 (C]O). H NMR (300 MHz, CDCl3): d 1.37 en
1
1.46(2!3H, s, CH3);2.75(1H, br s, OH); 3.92(3H, s, OCH3);
3.99 (1H, dd, JaxZ9.1 Hz, JbxZ1.9 Hz, 20-CH); 4.13 (1H, dd,
JabZ11.3 Hz, JaxZ9.1 Hz, 10-CHaHb); 4.65 (1H, dd, JabZ
11.3 Hz, JbxZ1.9 Hz, 10-CHaHb); 6.31 (1H, d, JZ9.6 Hz,
3-CH); 6.51 (1H, s, 5-CH); 7.61(1H, d, JZ9.6 Hz, 4-CH). 13C
NMR (75 MHz, CDCl3): d 25.1 en 26.0 (2!CH3); 56.4
(OCH3); 65.5 (10-CH2); 70.6 (30-Cq); 79.0 (20-Cq); 100.1
(5-CH); 111.6 (4a-Cq), 114.1 (3-CH); 132.4 (8-Cq); 136.7 (8a-
Cq); 139.0 (7-Cq); 143.8 (4-CH); 145.7 (6-Cq); 160.9 (C]O).
MS (70 eV, EI, m/z (%)): 293 (MC1, 35); 292 (MC, 99); 235
(26); 234 (100); 219 (57); 208 (46); 207 (23); 206 (23); 205
(78); 191 (23); 176 (25); 79 (35); 71 (21); 59 (92); 57 (52); 51
(26); 47 (23); 43 (75). Anal. Calcd for C15H16O6: C, 61.64%;
H, 5.52%. Found: C, 61.49%; H, 5.40%.
3.2.2. 7-(2,3-Epoxy-3-methylbutoxy)-8-hydroxy-6-meth-
oxycoumarin 10. 8-Hydroxy-6-methoxy-7-(30-methyl-20-
butenyloxy)coumarin (capensin) 8 (69 mg, 0.25 mmol) was
dissolved in 2.5 ml of ethyl acetate. The reaction mixture
was cooled to 0 8C and 52 mg (0.3 mmol) of 3-chloroper-
oxybenzoic acid was added, after which the reaction was
stirred at room temperature for 8 h. The solvent was
evaporated in vacuo and the resulting mixture was dissolved
in dichloromethane (25 ml) and washed with 25 ml of
saturated aqueous sodium bicarbonate and 20 ml of water,
respectively. The organic phase was dried (MgSO4) and
after filtration and evaporation of the solvent, 46 mg (63%)
of crude 7-(2,3-epoxy-3-methylbutoxy)-8-hydroxy-6-meth-
oxycoumarin 10 (purity: 95%) was obtained as a sticky
residue, which was used without further purification.
References and notes
IR (KBr, cmK1): 3419 (broad, OH); 1715 (C]O). 1H NMR
(300 MHz, CDCl3): d 1.32 en 1.38 (each 3H, each s,
(CH3)2C]), 3.23 (1H, dd, JZ6.60, 4.68 Hz, OCHCH2O),
3.90 (3H, s, OCH3), 4.16 (1H, dd, JZ6.60, 11.56 Hz,
OCHCHaHbO), 4.44 (1H, dd, JZ4.68, 11.56 Hz, OCHCHa-
HbO), 6.35 (1H, d, JZ9.63 Hz, 3-CH), 6.50 (1H, s, 5-CH),
1. Debenedetti, S. L.; Nadinic, E. L.; Coussio, J. D.; De Kimpe,
N.; Feneau-Dupont, J.; Declercq, J.-P. Phytochemistry 1991,
2757–2758.
2. Debenedetti, S. L.; Nadinic, E. L.; Gomez, M. A.; Coussio,
J. D.; De Kimpe, N.; Boeykens, M. Phytochemistry 1992,
3284–3285.